SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001408617-09-000010
Filing Date
2009-01-20
Accepted
2009-01-20 17:13:02
Documents
1
Period of Report
2008-07-15

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4/A  
1 PRIMARY DOCUMENT edgar.xml 4/A 4280
  Complete submission text file 0001408617-09-000010.txt   6071
Mailing Address 550 HILLS DRIVE BEDMINSTER NJ 07921
Business Address 550 HILLS DRIVE BEDMINSTER NJ 07921 (908) 450-5300
NPS PHARMACEUTICALS INC (Issuer) CIK: 0000890465 (see all company filings)

IRS No.: 870439579 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 383 COLOROW DRIVE SALT LAKE CITY X1 84108
Business Address 801-583-4939
Nader Francois (Reporting) CIK: 0001365343 (see all company filings)

Type: 4/A | Act: 34 | File No.: 000-23272 | Film No.: 09534833